Mycolactone as Analgesic: Subcutaneous Bioavailability Parameters
Jérémie Babonneau Dimitri Bréard Marie-Line Reynaert Estelle Marion David Guilet Jean-Paul Saint André Anne Croué Priscille Brodin Pascal Richomme Laurent Marsollier
Frontiers in Pharmacology, 2019-4-12
https://doi.org/10.3389/fphar.2019.00378
Priscille Brodin
Brodin Priscille
ORCID: 0000-0003-0991-7344
Email: priscille.brodin@inserm.fr
How can nanoparticles contribute to antituberculosis therapy? 10.1016/j.drudis.2017.01.011
Host-directed therapies offer novel opportunities for the fight against tuberculosis 10.1016/j.drudis.2017.05.005
A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone 10.3390/toxins9070227
A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone 10.3390/toxins9070227 10.3390/toxins9070227.
Clofazimine encapsulation in nanoporous silica particles for the oral treatment of antibiotic-resistant Mycobacterium tuberculosis infections 10.2217/nnm-2016-0364
Cyclodextrin-based nanocarriers containing a synergic drug combination: a potential formulation for pulmonary administration of antitubercular drugs 10.1016/j.ijpharm.2017.05.030 10.1016/j.ijpharm.2017.05.030.
Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism 10.1007/s00401-016-1652-z
Host-directed therapies offer novel opportunities for the fight against tuberculosis 10.1016/j.drudis.2017.05.005 10.1016/j.drudis.2017.05.005.
Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria 10.1111/mmi.13535
Impact of pe_ pgrs33 Gene Polymorphisms on Mycobacterium tuberculosis Infection and Pathogenesis 10.3389/fcimb.2017.00137
LppM impact on the colonization of macrophages by Mycobacterium tuberculosis 10.1111/cmi.12619
Phenotypic assays for Mycobacterium tuberculosis infection 10.1002/cyto.a.23129 10.1002/cyto.a.23129.
Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420 10.1126/science.aag1006
A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters 10.1039/c5ob02630j
Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro 10.1007/s00705-016-2771-5
Mycobacterium tuberculosis LppM Displays an Original Structure and Domain Composition Linked to a Dual Localization 10.1016/j.str.2016.07.009
Mycolactone The amazing analgesic mycobacterial toxin 10.1051/medsci/20163202007
STAT3 Represses Nitric Oxide Synthesis in Human Macrophages upon Mycobacterium tuberculosis Infection 10.1038/srep29297
2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1 10.1021/cb5007163
Cytosolic Access of Mycobacterium tuberculosis: Critical Impact of Phagosomal Acidification Control and Demonstration of Occurrence In Vivo 10.1371/journal.ppat.1004650
High content screening in chemical biology: overview and main challenges 10.1051/medsci/20153102016
High-Content Screening Technology Combined with a Human Granuloma Model as a New Approach To Evaluate the Activities of Drugs against Mycobacterium tuberculosis 10.1128/aac.03705-14
Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system 10.1016/j.vaccine.2015.03.083
Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro 10.3389/fmicb.2015.00438
Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action 10.1128/jvi.01473-15
Testing chemical and genetic Modulators in Mycobacterium tuberculosis infected cells using phenotypic assays 10.1007/978-1-4939-2450-9_24
A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening 10.3791/51114
Ligand Efficiency Driven Design of New Inhibitors of Mycobacterium tuberculosis Transcriptional Repressor EthR Using Fragment Growing, Merging, and Linking Approaches 10.1021/jm500422b
Mycobacterial Toxin Induces Analgesia in Buruli Ulcer by Targeting the Angiotensin Pathways 10.1016/j.cell.2014.04.040
Potent antiviral activity of Solanum rantonnetii and the isolated compounds against hepatitis C virus in vitro 10.1016/j.jff.2014.09.022
A novel specific edge effect correction method for RNA interference screenings 10.1093/bioinformatics/btr648
Discovery of Novel N-Phenylphenoxyacetamide Derivatives as EthR Inhibitors and Ethionamide Boosters by Combining High-Throughput Screening and Synthesis 10.1021/jm3003779
Ethionamide Boosters. 2. Combining Bioisosteric Replacement and Structure-Based Drug Design To Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors 10.1021/jm200825u
The Balance of Apoptotic and Necrotic Cell Death in Mycobacterium tuberculosis Infected Macrophages Is Not Dependent on Bacterial Virulence 10.1371/journal.pone.0047573
Analogous Mechanisms of Resistance to Benzothiazinones and Dinitrobenzamides in Mycobacterium smegmatis 10.1371/journal.pone.0026675
Ethionamide Boosters: Synthesis, Biological Activity, and Structure-Activity Relationships of a Series of 1,2,4-Oxadiazole EthR Inhibitors 10.1021/jm200076a
High-content screening in infectious diseases 10.1016/j.cbpa.2011.05.023
Functional characterization of the Mycobacterium tuberculosis serine/threonine kinase PknJ 10.1099/mic.0.038133-0
High Content Phenotypic Cell-Based Visual Screen Identifies Mycobacterium tuberculosis Acyltrehalose-Containing Glycolipids Involved in Phagosome Remodeling 10.1371/journal.ppat.1001100
High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery 10.4155/fmc.10.223
Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting 10.1016/j.biomaterials.2009.09.044
Automated High-Throughput siRNA Transfection in Raw 264.7 Macrophages: A Case Study for Optimization Procedure 10.1177/1087057108328762
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis 10.1126/science.1171583
High Content Screening Identifies Decaprenyl-Phosphoribose 2 ' Epimerase as a Target for Intracellular Antimycobacterial Inhibitors 10.1371/journal.ppat.1000645
Systematic Genetic Nomenclature for Type VII Secretion Systems 10.1371/journal.ppat.1000507
Control of M-tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP 10.1371/journal.ppat.0040033
Aquatic insects and transmission of Mycobacterium ulcerans 10.1051/medsci/20072367572
ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity 10.1128/jb.00469-07
Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis 10.1371/journal.ppat.0030062
Protection against mycobacterium ulcerans lesion development by exposure to aquatic insect saliva 10.1371/journal.pmed.0040064
Support vector machines for automatic detection of tuberculosis bacteria in confocal microscopy images 10.1109/isbi.2007.356794
Synthesis and antimycobacterial evaluation of benzofurobenzopyran analogues 10.1016/j.bmc.2006.12.009
An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis 10.1128/iai.74.4.2128-2137.2006
Benzofuro 3,2-f 1 benzopyrans: A new class of antitubercular agents 10.1016/j.bmc.2006.03.033
Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence 10.1128/iai.74.1.88-98.2006
High frequency of CD4(+) T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection 10.1128/iai.02086-05
Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence 10.1128/jb.00631-06
Evaluation of vaccines in the EU TB vaccine cluster using a guinea pig aerosol infection model of tuberculosis 10.1016/j.tube.2004.09.009
Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity 10.1074/jbc.M503515200
Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics 10.1099/mic.0.27799-0
Proteomic identification of M. tuberculosis protein kinase substrates: PknB recruits GarA, a FHA domain-containing protein, through activation loop-mediated interactions 10.1016/j.jmb.2005.05.049
Tuberculosis: from genome to vaccine 10.1586/14760584.4.4.541
Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RDI immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6 10.1128/iai.72.4.2170-2176.2004
Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens 10.1086/421468
ESAT-6 proteins: protective antigens and virulence factors? 10.1016/j.tim.2004.09.007
Macro-array and bioinformatic analyses reveal mycobacterial 'core' genes, variation in the ESAT-6 gene family and new phylogenetic markers for the Mycobacterium tuberculosis complex 10.1099/mic.0.26662-0
CD8(+)-T-cell responses of mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family 10.1128/iai.71.12.7173-7177.2003
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis 10.1038/nm859
A new evolutionary scenario for the Mycobacterium tuberculosis complex 10.1073/pnas.052548299
Bacterial artificial chromosome-based comparative genomic analysis identifies Mycobacterium microti as a natural ESAT-6 deletion mutant 10.1128/iai.70.10.5568-5578.2002
Disruption of HIV-1 integrase-DNA complexes by short 6-oxocytosine-containing oligonucleotides 10.1021/bi015732y
Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti 10.1046/j.1365-2958.2002.03237.x
6-Oxocytidine containing oligonucleotides inhibit the HIV-1 integrase in vitro 10.1081/ncn-100002322
Determinants of Mg2+-dependent activities of recombinant human immunodeficiency virus type 1 integrase 10.1021/bi000398b
Inhibition of the human immunodeficiency virus type 1 DNA integration by modified oligonucleotides 10.1023/a:1026631910681
Branched oligonucleotide-intercalator conjugate forming a parallel stranded structure inhibits HIV-1 integrase 10.1016/s0014-5793(99)01350-2
Inhibition of HIV-1 integration by mono- & bi-functionalized triple helix forming oligonucleotides 10.1080/07328319908044831
Optimization of alternate-strand triple helix formation at the 5 '-TpA-3 ' and 5 '-ApT-3 ' junctions 10.1093/nar/27.15.3029
A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus 10.1074/jbc.272.25.16010
Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids 10.1073/pnas.1707840114
ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton 10.15252/embr.201744371
ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton 10.15252/embr.201744371 10.15252/embr.201744371.
Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles 10.1038/s41598-017-05453-3
Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis 10.1038/s41598-017-11843-4 10.1038/s41598-017-11843-4.
Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays 10.1021/acschembio.7b00091
Host-pathogen systems for early drug discovery against tuberculosis 10.1016/j.mib.2017.11.017 10.1016/j.mib.2017.11.017.
Legionella pneumophila Modulates Mitochondrial Dynamics to Trigger Metabolic Repurposing of Infected Macrophages 10.1016/j.chom.2017.07.020 10.1016/j.chom.2017.07.020. Epub 2017 Aug 31.
Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling 10.1016/j.celrep.2017.08.101 10.1016/j.celrep.2017.08.101.
Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids 10.1073/pnas.1707840114 10.1073/pnas.1707840114.
Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry 10.1128/jvi.01982-17
Multiplexed Quantitation of Intraphagocyte Mycobacterium tuberculosis Secreted Protein Effectors 10.1016/j.celrep.2018.03.125
Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis 10.1016/j.bioorg.2018.08.025
Proteomics of Mycobacterium infection: Moving towards a Better Understanding of Pathogen-Driven immunomodulation 10.3389/fimmu.2018.00086
Synergy between circular bacteriocin AS-48 and ethambutol against Mycobacterium tuberculosis 10.1128/aac.00359-18
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase 10.1016/j.tube.2018.08.004
Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis 10.1038/s41598-017-11843-4
Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugs 10.1016/j.ijpharm.2017.05.030
Host-pathogen systems for early drug discovery against tuberculosis 10.1016/j.mib.2017.11.017
Legionella pneumophila Modulates Mitochondrial Dynamics to Trigger Metabolic Repurposing of Infected Macrophages 10.1016/j.chom.2017.07.020
Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling 10.1016/j.celrep.2017.08.101
Phenotypic assays for Mycobacterium tuberculosis infection 10.1002/cyto.a.23129
A fast, fully automated cell segmentation algorithm for high-throughput and high-content screening 10.1002/cyto.a.20627
Compartmentalized Encapsulation of Two Antibiotics in Porous Nanoparticles: an Efficient Strategy to Treat Intracellular Infections 10.1002/ppsc.201800360
Spatiotemporal Changes of the Phagosomal Proteome in Dendritic Cells in Response to LPS Stimulation 10.1074/mcp.RA119.001316
Mycolactone as Analgesic: Subcutaneous Bioavailability Parameters 10.3389/fphar.2019.00378
Intrinsic Antibacterial Activity of Nanoparticles Made of β-Cyclodextrins Potentiates Their Effect as Drug Nanocarriers against Tuberculosis 10.1021/acsnano.8b07902
Mitochondrial Dynamics and Activity in Legionella-Infected Cells 10.1007/978-1-4939-9048-1_13
Heparin-Binding Hemagglutinin Adhesin (HBHA) Is Involved in Intracytosolic Lipid Inclusions Formation in Mycobacteria 10.3389/fmicb.2018.02258
Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from Juncus maritimus, Is a New Inhibitor of Hepatitis C Virus RNA Replication 10.1128/jvi.02009-18
A novel codrug made of the combination of ethionamide and its potentiating booster: synthesis, self-assembly into nanoparticles and antimycobacterial evaluation 10.1039/C9OB00680J
Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls 10.3390/toxins11090516
Paradoxical Roles of the MAL/Tirap Adaptor in Pathologies. 10.3389/fimmu.2020.569127
Fragment-Based Optimized EthR Inhibitors with in Vivo Ethionamide Boosting Activity. 10.1021/acsinfecdis.9b00277
Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds. 10.1371/journal.pone.0227224
Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis. 10.1016/j.vaccine.2019.11.085
IRG1 controls immunometabolic host response and restricts intracellular Mycobacterium tuberculosis infection 10.1101/761551
Worms' Antimicrobial Peptides. 10.3390/md17090512
Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culture. 10.1371/journal.pone.0198226
Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro. 10.3389/fmicb.2015.00488
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. 10.1038/nm.3262
Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesis. 10.1021/jm300377g
Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease. 10.1186/1753-6561-5-s1-p38
Automated HTS/HCS for antivirals using visual HIV full replication assays. 10.1186/1742-4690-6-s2-p82
Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. 10.4049/jimmunol.174.6.3570
Cell microbiology interview 10.1111/cmi.13288
Pathogenomic analyses of Mycobacterium microti, an ESX-1-deleted member of the Mycobacterium tuberculosis complex causing disease in various hosts 10.1099/mgen.0.000505
Dimitri Bréard
Bréard Dimitri
ORCID: 0000-0001-6477-9592
Monitoring the Secretory Behavior of the Rat Adrenal Medulla by High-Performance Liquid Chromatography-Based Catecholamine Assay from Slice Supernatants 10.3389/fendo.2017.00248
Mammea-type coumarins from Mammea usambarensis Verdc. 10.1016/j.bse.2014.05.004
Additional Insights into Hypericum perforatum Content: Isolation, Total Synthesis, and Absolute Configuration of Hyperbiphenyls A and B from Immunomodulatory Root Extracts. 10.1021/acs.jnatprod.8b00325
Secondary metabolites from lichen as potent inhibitors of advanced glycation end products and vasodilative agents 10.1016/j.fitote.2018.10.015
Mycolactone as Analgesic: Subcutaneous Bioavailability Parameters 10.3389/fphar.2019.00378
Collected mass spectrometry data on monoterpene indole alkaloids from natural product chemistry research 10.1038/s41597-019-0028-3
Trade‐off between attraction to aggregation pheromones and repellent effects of spike lavender essential oil and its main constituent linalool in the flour beetle Tribolium confusum 10.1111/eea.12831
MixONat, a software for the dereplication of mixtures based on 13C NMR spectroscopy 10.1021/acs.analchem.0c00193
13C NMR Dereplication Using MixONat Software: A Practical Guide to Decipher Natural Products Mixtures 10.1055/a-1470-0446
Behavioral and Antennal Responses of Tribolium confusum to Varronia globosa Essential Oil and Its Main Constituents: Perspective for Their Use as Repellent 10.3390/molecules26154393
Toxicity and mode of action of the aporphine plant alkaloid liriodenine on the insect GABA receptor 10.1016/j.toxicon.2021.08.019
Estelle Marion
Marion Estelle
ORCID: 0000-0003-4917-9665
Chitin promotesMycobacterium ulceransgrowth 10.1093/femsec/fiw067
Clinical Features of Spontaneous Partial Healing During Mycobacterium ulcerans Infection 10.1093/ofid/ofw013
FVB/N Mice Spontaneously Heal Ulcerative Lesions Induced by Mycobacterium ulcerans and Switch M. ulcerans into a Low Mycolactone Producer 10.4049/jimmunol.1502194
A Field Study in Benin to Investigate the Role of Mosquitoes and Other Flying Insects in the Ecology of Mycobacterium ulcerans 10.1371/journal.pntd.0003941
Buruli Ulcer in South Western Nigeria: A Retrospective Cohort Study of Patients Treated in Benin 10.1371/journal.pntd.0003443
Development of a Dry-Reagent-Based qPCR to Facilitate the Diagnosis of Mycobacterium ulcerans Infection in Endemic Countries 10.1371/journal.pntd.0003606
Simple, Rapid Mycobacterium ulcerans Disease Diagnosis from Clinical Samples by Fluorescence of Mycolactone on Thin Layer Chromatography 10.1371/journal.pntd.0004247
A case of guilt by association: Water bug bite incriminated in M. ulcerans infection 10.1016/j.ijmyco.2014.01.004
Buruli Ulcer Disease in Republic of the Congo 10.3201/eid2006.131498
Establishment of Quantitative PCR (qPCR) and Culture Laboratory Facilities in a Field Hospital in Benin: 1-Year Results 10.1128/jcm.02131-14
Findings in Patients From Benin With Osteomyelitis and Polymerase Chain Reaction-Confirmed Mycobacterium ulcerans Infection 10.1093/cid/ciu584
First Detection of Mycobacterium ulcerans DNA in Environmental Samples from South America 10.1371/journal.pntd.0002660
Mycobacterial Toxin Induces Analgesia in Buruli Ulcer by Targeting the Angiotensin Pathways 10.1016/j.cell.2014.04.040
Buruli ulcer: a dynamic transversal research model performed through the international network of Pasteur Institutes 10.1051/medsci/20132910021
Parasitic genotypes appear to differ in leishmaniasis patients compared with asymptomatic related carriers 10.1016/j.ijpara.2012.12.008
Regulation of Mycolactone, the Mycobacterium ulcerans Toxin, Depends on Nutrient Source 10.1371/journal.pntd.0002502
Photodegradation of the Mycobacterium ulcerans Toxin, Mycolactones: Considerations for Handling and Storage 10.1371/journal.pone.0033600
Geographic Expansion of Buruli Ulcer Disease, Cameroon 10.3201/eid1703091859
Buruli Ulcer, Central African Republic 10.3201/eid1604.090195
Seasonal and Regional Dynamics of M. ulcerans Transmission in Environmental Context: Deciphering the Role of Water Bugs as Hosts and Vectors 10.1371/journal.pntd.0000731
Use of Fine-Needle Aspiration for Diagnosis of Mycobacterium ulcerans Infection 10.1128/jcm.00558-10
Mycolactone Gene Expression Is Controlled by Strong SigA-Like Promoters with Utility in Studies of Mycobacterium ulcerans and Buruli Ulcer 10.1371/journal.pntd.0000553
Mycolactone toxin induces an inflammatory response by targeting the IL-1β pathway: Mechanistic insight into Buruli ulcer pathophysiology 10.1371/journal.ppat.1009107
High antibody titres induced by protein subunit vaccines using Mycobacterium ulcerans antigens Hsp18 and MUL_3720 with a TLR-2 agonist fail to protect against Buruli ulcer in mice 10.7717/peerj.9659
Genome-wide association study of Buruli ulcer in rural Benin highlights role of two LncRNAs and the autophagy pathway 10.1038/s42003-020-0920-6
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial 10.1016/s0140-6736(20)30047-7
Skin-specific antibodies neutralizing mycolactone toxin during the spontaneous healing of Mycobacterium ulcerans infection 10.1126/sciadv.aax7781
Stable and Local Reservoirs of Mycobacterium ulcerans Inferred from the Nonrandom Distribution of Bacterial Genotypes, Benin 10.3201/eid2603.190573
Vaccine-Specific Immune Responses against Mycobacterium ulcerans Infection in a Low-Dose Murine Challenge Model 10.1128/iai.00753-19
Senegal, a new potential endemic country for Buruli ulcer? 10.1016/j.ijid.2019.09.020
Effect of well drilling on Buruli ulcer incidence in Benin: a case-control, quantitative survey 10.1016/s2542-5196(19)30110-x
Mycolactone as Analgesic: Subcutaneous Bioavailability Parameters 10.3389/fphar.2019.00378
Microdeletion on chromosome 8p23.1 in a familial form of severe Buruli ulcer 10.1371/journal.pntd.0006429
The potent effect of mycolactone on lipid membranes 10.1371/journal.ppat.1006814
A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone 10.3390/toxins9070227
Mouse model of colonization of the digestive tract withAcinetobacter baumanniiand subsequent pneumonia 10.2217/fmb-2016-0203
Draft Genome Sequence of Mycobacterium ulcerans S4018 Isolated from a Patient with an Active Buruli Ulcer in Benin, Africa 10.1128/genomea.00248-17
An Optimized Method for Extracting Bacterial RNA from Mouse Skin Tissue Colonized by Mycobacterium ulcerans 10.3389/fmicb.2017.00512
Multiple introductions and recent spread of the emerging human pathogen Mycobacterium ulcerans across Africa 10.1093/gbe/evx003
David Guilet
Guilet David
ORCID: 0000-0003-2828-7755
ortho-prenylphenol photooxygenation as a straightforward access to ortho-(2-hydroxy-3-methylbut-3-enyl)phenols 10.1016/S0040-4039(00)00657-2
Modulation of P-glycoprotein activity by acridones and coumarins from Citrus sinensis 10.1002/ptr.2081
Comparison of two methods, UHPLC-UV and UHPLC-MS/MS, for the quantification of polyphenols in cider apple juices 10.3390/molecules180910213
Paradoxical effects of polyphenolic compounds from Clusiaceae on angiogenesis 10.1016/j.bcp.2011.12.002
Cytotoxic and antiplasmodial xanthones from Pentadesma butyracea 10.1021/np8005953
Antifungal isopimaranes from Hypoestes serpens 10.1016/S0031-9422(03)00154-7
HPLC-UV/PAD and HPLC-MSn analyses of leaf and root extracts of Vismia guineensis and isolation and identification of two new bianthrones 10.1002/pca.788
Isoflavonoids in non-leguminous families: An update 10.1039/b416248j
Sesquiterpenes from aerial parts of Ferula vesceritensis 10.1016/j.phytochem.2008.03.010
Normal phase HPLC-based activity profiling of non-polar crude plant extracts – acetylcholinesterase inhibiting guttiferones from Montrouziera cauliflora as a case study 10.1080/14786419.2016.1154054
Antiangiogenic tocotrienol derivatives from garcinia amplexicaulis 10.1021/np400598y
Bioguided fractionation and isolation of natural inhibitors of advanced glycation end-products (AGEs) from Calophyllum flavoramulum 10.1016/j.phytochem.2012.02.006
Breast cancer resistance protein (BCRP/ABCG2): New inhibitors and QSAR studies by a 3D linear solvation energy approach 10.1016/j.ejps.2009.05.012
On-line identification of tropane alkaloids from Erythroxylum vacciniifolium by liquid chromatography-UV detection-multiple mass spectrometry and liquid chromatography-nuclear magnetic resonance spectrometry 10.1016/j.chroma.2003.08.052
Selective modulation of P-glycoprotein activity by steroidal saponines from Paris polyphylla 10.1016/j.fitote.2008.09.010
Cytotoxic coumarins from Calophyllum dispar 10.1016/S0031-9422(01)00285-0
QTL analysis and candidate gene mapping for the polyphenol content in cider apple 10.1371/journal.pone.0107103
Bithiophenic MALDI matrices as valuable leads for the selective detection of alkaloids 10.1007/s00216-017-0634-x
A tocotrienol series with an oxidative terminal prenyl unit from Garcinia amplexicaulis 10.1016/j.phytochem.2014.10.024
Inhibitory effects of the carrot metabolites 6-methoxymellein and falcarindiol on development of the fungal leaf blight pathogen Alternaria dauci 10.1016/j.pmpp.2012.10.002
Novel cytotoxic 4-phenylfuranocoumarins from Calophyllum dispar 10.1021/np000517o
Efficient Semi-Synthesis of Natural δ-(R)-Tocotrienols from a Renewable Vegetal Source 10.1021/acs.jnatprod.8b00517
Antifungal Chromans Inhibiting the Mitochondrial Respiratory Chain of Pea Seeds and New Xanthones from Calophyllum caledonicum 10.1055/s-2003-818004
Endogenous metabolites of vitamin E limit inflammation by targeting 5-lipoxygenase 10.1038/s41467-018-06158-5
Tropane alkaloids from the bark of Erythroxylum vacciniifolium 10.1021/np020512m
Absolute configuration of a tetrahydrophenanthrene from Heliotropium ovalifolium by LC-NMR of its mosher esters 10.1021/np020366k
Polyphenol variability in the fruits and juices of a cider apple progeny 10.1002/jsfa.6411
Potential of extracts from Saponaria officinalis and Calendula officinalis to modulate in vitro rumen fermentation with respect to their content in saponins 10.1080/09168451.2014.882742
Dihydrochalcones: Implication in resistance to oxidative stress and bioactivities against advanced glycation end-products and vasoconstriction 10.1016/j.phytochem.2009.11.004
Isoflavones from Ficus nymphaefolia 10.1080/14786410601086871
Methylpyrrole tropane alkaloids from the bark of Erythroxylum vacciniifolium 10.1021/np040144h
Flavonoids of aerial parts of an endemic species of the Apiaceae of Algeria, Ammoides atlantica 10.1007/s10600-008-9110-3
Mycolactone as analgesic: Subcutaneous bioavailability parameters 10.3389/fphar.2019.00378
Antifungal diterpenes from Hypoestes serpens (Acanthaceae) 10.1016/S0031-9422(02)00551-4
Semisynthetic and Natural Garcinoic Acid Isoforms as New mPGES-1 Inhibitors 10.1055/s-0042-108739
Structure-activity relationship of natural and synthetic coumarins inhibiting the multidrug transporter P-glycoprotein 10.1016/j.bmc.2006.06.026
Regioselectivity in the ene reaction of singlet oxygen with ortho-prenylphenol derivatives 10.1016/S0040-4020(03)00733-6
6-Acylcoumarins from Mesua racemosa 10.1016/S0031-9422(98)00688-8
Flavonoids of Retama sphaerocarpa leaves and their antimicrobial activities 10.1007/s10600-007-0207-x
Inhibition of P-glycoprotein-mediated multidrug efflux by aminomethylene and ketomethylene analogs of reversins 10.1016/j.bmcl.2006.07.059
Covalent association of polyaza macrocyclic units to the electroactive tetrathiafulvalene moiety: Synthesis and structural analysis 10.1016/S1631-0748(03)00084-5
Polyphenolic Compounds with Anti-Ages Activity from Three Clusiaceae Plants 10.9734/ejmp/2014/10812
Quantification of small quantities of a standardized Dry Grape Extract in complete feed using UHPLC-MS/MS {10.1055/s-0039-3399772}
Characterization of glycosylated flavonoids obtained from enzymatic reaction by matrix free laser desorption ionization mass spectrometry (LDI-MS) {10.1055/s-0039-3400149}
Marsollier Laurent
Laurent Marsollier
ORCID: 0000-0001-5497-5995
High antibody titres induced by protein subunit vaccines using Mycobacterium ulcerans antigens Hsp18 and MUL_3720 with a TLR-2 agonist fail to protect against Buruli ulcer in mice. 10.7717/peerj.9659
Genome-wide association study of Buruli ulcer in rural Benin highlights role of two LncRNAs and the autophagy pathway. 10.1038/s42003-020-0920-6
Vaccine-Specific Immune Responses against Mycobacterium ulcerans Infection in a Low-Dose Murine Challenge Model. 10.1128/iai.00753-19
Senegal, a new potential endemic country for Buruli ulcer? 10.1016/j.ijid.2019.09.020
Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls. 10.3390/toxins11090516
Mycolactone as Analgesic: Subcutaneous Bioavailability Parameters. 10.3389/fphar.2019.00378
Microdeletion on chromosome 8p23.1 in a familial form of severe Buruli ulcer. 10.1371/journal.pntd.0006429
The potent effect of mycolactone on lipid membranes. 10.1371/journal.ppat.1006814
ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton. 10.15252/embr.201744371
A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone. 10.3390/toxins9070227
Mouse model of colonization of the digestive tract with Acinetobacter baumannii and subsequent pneumonia. 10.2217/fmb-2016-0203
Ecology and Feeding Habits Drive Infection of Water Bugs with Mycobacterium ulcerans. 10.1007/s10393-017-1228-y
Draft Genome Sequence of Mycobacterium ulcerans S4018 Isolated from a Patient with an Active Buruli Ulcer in Benin, Africa. 10.1128/genomea.00248-17
An Optimized Method for Extracting Bacterial RNA from Mouse Skin Tissue Colonized by Mycobacterium ulcerans. 10.3389/fmicb.2017.00512
Multiple Introductions and Recent Spread of the Emerging Human Pathogen Mycobacterium ulcerans across Africa. 10.1093/gbe/evx003
Deforestation-driven food-web collapse linked to emerging tropical infectious disease, Mycobacterium ulcerans. 10.1126/sciadv.1600387
Chitin promotes Mycobacterium ulcerans growth. 10.1093/femsec/fiw067
Molecular Species Delimitation and Morphology of Aquatic and Sub-Aquatic Bugs (Heteroptera) in Cameroon. 10.1371/journal.pone.0154905
FVB/N Mice Spontaneously Heal Ulcerative Lesions Induced by Mycobacterium ulcerans and Switch M. ulcerans into a Low Mycolactone Producer. 10.4049/jimmunol.1502194
[Mycolactone: the amazing analgesic mycobacterial toxin]. 10.1051/medsci/20163202007
Clinical Features of Spontaneous Partial Healing During Mycobacterium ulcerans Infection. 10.1093/ofid/ofw013
Seasonal Patterns of Buruli Ulcer Incidence, Central Africa, 2002-2012. 10.3201/eid2108.141336
Mycobacterium ulcerans dynamics in aquatic ecosystems are driven by a complex interplay of abiotic and biotic factors. 10.7554/elife.07616
Development of a dry-reagent-based qPCR to facilitate the diagnosis of Mycobacterium ulcerans infection in endemic countries. 10.1371/journal.pntd.0003606
Extrahuman epidemiology of Acinetobacter baumannii in Lebanon. 10.1128/aem.03824-14
Mycobacterium ulcerans disease (Buruli ulcer) in Mali: A new potential African endemic country. 10.2340/00015555-1942
Buruli ulcer in South Western Nigeria: a retrospective cohort study of patients treated in Benin. 10.1371/journal.pntd.0003443
[Detection of the IS2404 insertion sequence and ketoreductase produced by Mycobacterium ulcerans in the aquatic Heteroptera in the health districts of Dabou and Tiassalé in Côte d'Ivoire]. 10.1684/mst.2014.0363
Topography and land cover of watersheds predicts the distribution of the environmental pathogen Mycobacterium ulcerans in aquatic insects. 10.1371/journal.pntd.0003298
Defining and targeting high-risk populations in Buruli ulcer--authors' reply. 10.1016/s2214-109x(14)70312-2
Buruli ulcer acquired in Mali: a rare and atypical situation. 10.1016/j.tmaid.2014.09.009
Findings in patients from Benin with osteomyelitis and polymerase chain reaction-confirmed Mycobacterium ulcerans infection. 10.1093/cid/ciu584
HIV infection and Buruli ulcer in Africa. 10.1016/s1473-3099(14)70882-5
Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study. 10.1016/s2214-109x(14)70223-2
Mycobacterial toxin induces analgesia in buruli ulcer by targeting the angiotensin pathways. 10.1016/j.cell.2014.04.040
A case of guilt by association: Water bug bite incriminated in M. ulcerans infection. 10.1016/j.ijmyco.2014.01.004
Buruli ulcer disease in Republic of the Congo. 10.3201/eid2006.131498
Mycobacterium ulcerans ecological dynamics and its association with freshwater ecosystems and aquatic communities: results from a 12-month environmental survey in Cameroon. 10.1371/journal.pntd.0002879
First detection of Mycobacterium ulcerans DNA in environmental samples from South America. 10.1371/journal.pntd.0002660
[Buruli ulcer: a dynamic transversal research model performed through the international network of Pasteur Institutes]. 10.1051/medsci/20132910021
Photodegradation of the Mycobacterium ulcerans toxin, mycolactones: considerations for handling and storage. 10.1371/journal.pone.0033600
Adequate wound care and use of bed nets as protective factors against Buruli Ulcer: results from a case control study in Cameroon. 10.1371/journal.pntd.0001392
Geographic expansion of Buruli ulcer disease, Cameroon. 10.3201/eid1703.091859
Oral treatment for Mycobacterium ulcerans infection: results from a pilot study in Benin. 10.1093/cid/ciq072
Serological evaluation of Mycobacterium ulcerans antigens identified by comparative genomics. 10.1371/journal.pntd.0000872
Use of fine-needle aspiration for diagnosis of Mycobacterium ulcerans infection. 10.1128/jcm.00558-10
Buruli ulcer, Central African Republic. 10.3201/eid1604.090195
Mycolactone gene expression is controlled by strong SigA-like promoters with utility in studies of Mycobacterium ulcerans and buruli ulcer. 10.1371/journal.pntd.0000553
High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors. 10.1371/journal.ppat.1000645
Buruli ulcer in long-term traveler to Senegal. 10.3201/eid1501.080123
Optimized method for preparation of DNA from pathogenic and environmental mycobacteria. 10.1128/aem.01358-08
Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv. 10.1074/jbc.m802115200
Comprehensive proteome analysis of Mycobacterium ulcerans and quantitative comparison of mycolactone biosynthesis. 10.1002/pmic.200701018
Risk factors for buruli ulcer: a case control study in Cameroon. 10.1371/journal.pntd.0000101
[Aquatic insects and transmission of Mycobacterium ulcerans]. 10.1051/medsci/20072367572
Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis. 10.1371/journal.ppat.0030062
Protection against Mycobacterium ulcerans lesion development by exposure to aquatic insect saliva. 10.1371/journal.pmed.0040064
Early trafficking events of Mycobacterium ulcerans within Naucoris cimicoides. 10.1111/j.1462-5822.2006.00790.x
Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence. 10.1128/jb.00631-06
Immunogenicity of Mycobacterium ulcerans Hsp65 and protective efficacy of a Mycobacterium leprae Hsp65-based DNA vaccine against Buruli ulcer. 10.1016/j.micinf.2006.03.009
Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence. 10.1128/iai.74.1.88-98.2006
Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin. 10.1111/j.1462-5822.2005.00546.x
Colonization of the salivary glands of Naucoris cimicoides by Mycobacterium ulcerans requires host plasmatocytes and a macrolide toxin, mycolactone. 10.1111/j.1462-5822.2005.00521.x
[Diagnosis of Mycobacterium ulcerans infections in French Guiana]. 10.1016/s0755-4982(04)98974-9
Aquatic snails, passive hosts of Mycobacterium ulcerans. 10.1128/aem.70.10.6296-6298.2004
Aquatic plants stimulate the growth of and biofilm formation by Mycobacterium ulcerans in axenic culture and harbor these bacteria in the environment. 10.1128/aem.70.2.1097-1103.2004
Susceptibility of Mycobacterium ulcerans to a combination of amikacin/rifampicin. 10.1016/s0924-8579(03)00240-1
[Ecology and transmission of Mycobacterium ulcerans]. 10.1016/s0369-8114(03)00151-2
Isolation of three Mycobacterium ulcerans strains resistant to rifampin after experimental chemotherapy of mice. 10.1128/aac.47.4.1228-1232.2003
Aquatic insects as a vector for Mycobacterium ulcerans. 10.1128/aem.68.9.4623-4628.2002
Summary of the Sussex-Huawei locomotion-transportation recognition challenge
Observation of a manifold in the chaotic phase space of an asymmetric optical microcavity
Localized temporal variation of Earth's inner-core boundary from high-quality waveform doublets
Off-axis multi-wavelength dispersion controlling metalens for multi-color imaging
Impact of United States political sanctions on international collaborations and research in Iran